Correlation Between GeoVax Labs and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GeoVax Labs and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeoVax Labs and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeoVax Labs and Salarius Pharmaceuticals, you can compare the effects of market volatilities on GeoVax Labs and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeoVax Labs with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeoVax Labs and Salarius Pharmaceuticals.
Diversification Opportunities for GeoVax Labs and Salarius Pharmaceuticals
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between GeoVax and Salarius is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding GeoVax Labs and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and GeoVax Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeoVax Labs are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of GeoVax Labs i.e., GeoVax Labs and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between GeoVax Labs and Salarius Pharmaceuticals
Given the investment horizon of 90 days GeoVax Labs is expected to under-perform the Salarius Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, GeoVax Labs is 4.56 times less risky than Salarius Pharmaceuticals. The stock trades about -0.17 of its potential returns per unit of risk. The Salarius Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 141.00 in Salarius Pharmaceuticals on December 3, 2024 and sell it today you would lose (33.00) from holding Salarius Pharmaceuticals or give up 23.4% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
GeoVax Labs vs. Salarius Pharmaceuticals
Performance |
Timeline |
GeoVax Labs |
Salarius Pharmaceuticals |
GeoVax Labs and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GeoVax Labs and Salarius Pharmaceuticals
The main advantage of trading using opposite GeoVax Labs and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeoVax Labs position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.GeoVax Labs vs. Zura Bio Limited | GeoVax Labs vs. ZyVersa Therapeutics | GeoVax Labs vs. Phio Pharmaceuticals Corp | GeoVax Labs vs. Sonnet Biotherapeutics Holdings |
Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |